US Broker Ratings

Abbott Laboratories (ABT) Stock Analysis: Navigating the 25% Potential Upside in Healthcare Innovation

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to draw attention from investors due to its robust portfolio and promising market position. With a market capitalization of..

DaVita Inc. (DVA) Stock Analysis: Navigating the Waters of Healthcare Investment with Strong Revenue Growth

DaVita Inc. (NYSE: DVA) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. Renowned for its focus on kidney dialysis services, DaVita has..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Market Volatility with a 9.43% Upside Potential

Illumina, Inc. (NASDAQ: ILMN), a titan in the diagnostics and research sector of the healthcare industry, presents a compelling opportunity for investors with its innovative solutions in genetic and genomic..

STERIS plc (STE) Stock Analysis: Unveiling a 27.82% Potential Upside for Investors

STERIS plc (NYSE: STE), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity for discerning investors. With a market capitalization of $21.6 billion,..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Exploring an 89.61% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, has been capturing investor attention with its promising portfolio in the biopharmaceutical landscape. Headquartered in Miami, Florida, Summit..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 13.48% Potential Upside Amid Robust Oncology Portfolio

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is gaining traction with its innovative oncology solutions. Headquartered in Alameda, California, Exelixis is dedicated to the discovery, development,..

Revvity, Inc. (RVTY) Investor Outlook: Unlocking a Potential 39% Upside in Healthcare Diagnostics

Revvity, Inc. (NASDAQ: RVTY), a prominent player in the healthcare diagnostics and research industry, offers investors a compelling opportunity with a potential upside of 39.12%, according to current analyst ratings...

Royalty Pharma plc (RPRX) Stock Analysis: Discovering a 13.66% Upside with Robust Analyst Ratings

Investors with a keen eye on the healthcare sector might want to take a closer look at Royalty Pharma plc (NASDAQ: RPRX), a notable player in the biotechnology industry. With..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A Potential 64% Upside for Savvy Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, offers a unique investment opportunity with a remarkable potential upside of 64.18% according to recent analyst ratings. With..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Unveiling a 39% Potential Upside with Strong Analyst Support

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents a compelling investment opportunity for those eyeing robust..

Stryker Corporation (SYK) Stock Report: Exploring a 26% Potential Upside for Investors

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, stands at the forefront of the medical devices industry with a substantial market capitalization of $128.46 billion. Headquartered in Portage,..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential and Market Position

Dr. Reddy’s Laboratories Ltd (RDY), a prominent player in the healthcare sector, continues to be a focal point for investors seeking exposure in the drug manufacturing industry, particularly in specialty..

Novartis AG (NVS) Stock Analysis: Navigating Opportunities with Strategic Insights

For investors looking to delve into the healthcare sector, Novartis AG (NYSE: NVS) presents a compelling case with its robust portfolio and strategic focus in drug manufacturing. Despite recent market..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating a 9.12% Potential Upside for Investors

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable entity within the healthcare sector, specifically in the general drug manufacturing industry. With a substantial market capitalization of $117.06 billion, the..

Edwards Lifesciences (EW) Stock Analysis: Exploring a 16.93% Potential Upside for the Medical Devices Leader

For investors seeking exposure to the healthcare sector, Edwards Lifesciences Corporation (NYSE: EW) presents a compelling opportunity. As a leader in the medical devices industry, Edwards Lifesciences specializes in innovative..

Pfizer, Inc. (PFE) Stock Analysis: Navigating Valuation Challenges and Dividend Opportunities

Pfizer, Inc. (NYSE: PFE) remains a formidable player in the healthcare sector, boasting a market capitalization of $153.41 billion. As a leading entity in the drug manufacturing industry, Pfizer continues..

Merck & Company, Inc. (MRK): Analyst Consensus and 12% Upside Potential for Investors

Merck & Company, Inc. (NYSE: MRK) stands as a pillar in the healthcare sector, specifically within the general drug manufacturing industry. With a formidable market capitalization of $282.3 billion, Merck..

Philips (PHG) Stock Analysis: A 33.90% Potential Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing opportunity. Currently priced at $26.25, the stock offers a potential upside of 33.90%,..

DexCom, Inc. (DXCM) Investor Outlook: Analyst Consensus Points to 28.63% Upside Potential

DexCom, Inc. (DXCM), a prominent player in the healthcare sector, specializes in the medical devices industry with a focus on continuous glucose monitoring (CGM) systems. Based in San Diego, California,..

Zoetis Inc. (ZTS) Stock Analysis: Unlocking a 30.54% Potential Upside in Healthcare Innovation

Zoetis Inc. (NYSE: ZTS), a leader in the healthcare sector, specializes in the development and commercialization of a wide array of animal health products. With a significant market cap of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds